In addition, from five SNPs identified from systematic review, only ERCC1 rs3212986 was associated with a higher risk of cisplatin-induced nephrotoxicity in the validation cohort of NSCLC patients. The gene discussed is ERCC1; the disease is non-small cell lung carcinoma.